StockData
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. (CMMB) stock

CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 5/30
$1.64+0.02 (+1.23%)

Close on Nov 17, 2026Market cap $11.80MP/E 1.1Yield –

Chemomab Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Chemomab Therapeutics's market cap was $9.78M on Nov 11, 2026, against $13.55M a year earlier. Over the last 5 years it ranged from $6.33M to $78.64M, with a median of $18.03M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$9.78M+14.6%
2025Dec 31, 2025$8.54M-67.2%
2024Dec 31, 2024$25.99M+310.9%
2023Dec 29, 2023$6.33M-82.7%
2022Dec 30, 2022$36.64M-53.4%
2021Dec 31, 2021$78.64M-56.2%
2020Dec 31, 2020$179.71M+194.3%
2019Dec 31, 2019$61.06M–

More Chemomab Therapeutics figures

See a number that looks wrong?